EUVIMEDEUVIMED entdecken
Crossref

Changing Cirrhosis Burden in the MENA Region, 1990–2021: From Premature Mortality to Disability (Global Burden of Disease)

Razan Emad, Siham AlSinani, Mohamed El-Kassas iD, Mohamed Eslam, Saleh A Alqahtani, Yusuf Yilmaz, Bashar Emad, Khalid A Alswat iD, Samer Alduri, Faisal M Sanai, Faisal Abaalkhail, Khalid M AlNaamani iD

Liver International · 2026-05 · 46 (5)

DOI: 10.1111/liv.70605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 26.03.2026. Verfasst von Razan Emad und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Jordan University Hospital, Amman, Jordan. Hauptthemen laut MEDLINE: Liver Cirrhosis, Mortality, Premature. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cirrhosis is a major contributor to disease burden in the Middle East and North Africa (MENA) region, with variations in outcomes across socioeconomic contexts and etiologies. The primary aim of this study was to assess the temporal trends in cirrhosis‐related mortality and disability across the MENA region, with a focus on variations by aetiology and Socio‐demographic Index (SDI). By identifying patterns and disparities in disease burden, the study seeks to support evidence‐based policymaking and optimise regional liver health planning efforts.

Methods

We analysed age‐standardised data from the Global Burden of Disease Study to evaluate cirrhosis burden in the MENA region by SDI level in 2021 and by etiologic subtype in 1990 and 2021. Burden metrics included disability‐adjusted life years (DALYs), years of life lost (YLLs), years lived with disability (YLDs), and the YLL‐to‐YLD ratio, applied as a novel epidemiologic indicator to illustrate evolving patterns in disease mortality versus chronicity. Aetiology‐specific trends were quantified using Estimated Annual Percentage Change (EAPC) and stratified by SDI to assess variability across countries and over time.

Results

In 2021, cirrhosis burden varied markedly by SDI in the MENA region. Low‐SDI countries experienced the highest YLL‐to‐YLD ratio (122.2), reflecting a predominantly fatal disease course, whereas high‐middle and high‐SDI countries demonstrated lower ratios (51.3 and 56.1, respectively), indicating improved survival but with more patients living longer with disability. From 1990 to 2021, the total age‐standardised DALY rate for cirrhosis decreased from 18498.2 in 1990–9749.3 in 2021, with the YLL‐to‐YLD ratio dropping from 123.6 to 71, signalling a transition toward less fatal and more manageable disease. Aetiology‐specific trends showed consistent decreases in YLL‐to‐YLD ratios across all causes: chronic hepatitis C (186.6–108.5), chronic hepatitis B (180.4–105.1), alcohol‐related cirrhosis (188.4–116.1), and non‐alcoholic fatty liver disease (166.6–94.4). Cirrhosis from other causes remained the most disability‐predominant subtype (YLL‐to‐YLD ratio 25.6 in 2021).

Conclusions

Cirrhosis in the MENA region is undergoing a transition from fatal disease to a chronically disabling condition. These changes reflect advances in detection, treatment, and survival, but also underscore the need for policy adaptation to improve awareness, prevention, early diagnosis, expand long‐term care infrastructure, and reduce disparities across SDI levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisMortality, PrematureHumansDisability-Adjusted Life YearsGlobal Burden of DiseaseMiddle EastAfrica, NorthernFemaleMaleMiddle AgedAdultCost of Illness

Stichwörter der Autor:innen

DALYsGBDMENAYLDsYLLscirrhosisdisabilitylife lostsociodemographic index

Autor:innen und Institutionen

  • Department of Medicine, Jordan University Hospital, Amman, Jordan.
  • Department of Child Health, Sultan Qaboos University Hospital, University Medical City, Muscat, Oman.
  • Department of Child Health, Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman.
  • Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
  • Steatotic Liver Diseases Study Foundation in Middle East and North Africa (SLMENA), Cairo, Egypt.
  • Applied Science Research Center, Applied Science Private University, Amman, Jordan.

ORCID-Profile: Mohamed El-Kassas, Khalid A Alswat, Khalid M AlNaamani

Zitieren

APA

Emad, R., AlSinani, S., El-Kassas, M., Eslam, M., Alqahtani, S. A., Yilmaz, Y., Emad, B., Alswat, K. A., Alduri, S., Sanai, F. M., Abaalkhail, F., & AlNaamani, K. M. (2026). Changing Cirrhosis Burden in the MENA Region, 1990–2021: From Premature Mortality to Disability (Global Burden of Disease). Liver International, 46(5). https://doi.org/10.1111/liv.70605

Vancouver

Emad R, AlSinani S, El-Kassas M, Eslam M, Alqahtani SA, Yilmaz Y, et al. Changing Cirrhosis Burden in the MENA Region, 1990–2021: From Premature Mortality to Disability (Global Burden of Disease). Liver International. 2026;46(5). doi:10.1111/liv.70605

BibTeX
@article{Emad2026,
  author = {Emad, Razan and AlSinani, Siham and El-Kassas, Mohamed and Eslam, Mohamed and Alqahtani, Saleh A and Yilmaz, Yusuf and Emad, Bashar and Alswat, Khalid A and Alduri, Samer and Sanai, Faisal M and Abaalkhail, Faisal and AlNaamani, Khalid M},
  title = {Changing Cirrhosis Burden in the MENA Region, 1990–2021: From Premature Mortality to Disability (Global Burden of Disease)},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {5},
  doi = {10.1111/liv.70605}
}
Kostenlos starten →